CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 53 filers reported holding CYTEIR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,920,916 | -79.8% | 676,379 | -81.5% | 0.14% | -80.7% |
| Q2 2023 | $9,522,854 | -91.6% | 3,662,636 | -7.0% | 0.74% | -90.1% |
| Q1 2023 | $112,892,832 | +1636.4% | 3,940,413 | 0.0% | 7.45% | +1734.7% |
| Q4 2022 | $6,501,681 | -14.1% | 3,940,413 | 0.0% | 0.41% | +12.5% |
| Q3 2022 | $7,566,000 | -47.7% | 3,940,413 | -18.6% | 0.36% | -49.4% |
| Q2 2022 | $14,473,000 | -20.7% | 4,840,413 | 0.0% | 0.71% | -26.0% |
| Q1 2022 | $18,248,000 | -66.8% | 4,840,413 | 0.0% | 0.96% | -63.0% |
| Q4 2021 | $55,035,000 | -35.2% | 4,840,413 | 0.0% | 2.61% | -40.7% |
| Q3 2021 | $84,949,000 | -18.0% | 4,840,413 | 0.0% | 4.39% | -4.4% |
| Q2 2021 | $103,585,000 | – | 4,840,413 | – | 4.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 2,459,572 | $6,985,184 | 15.71% |
| BML Capital Management, LLC | 3,250,008 | $9,230,023 | 8.48% |
| Newtyn Management, LLC | 2,500,444 | $7,101,261 | 1.75% |
| VR Advisory Services Ltd | 1,072,968 | $3,047,229 | 1.08% |
| Anson Funds Management LP | 1,324,114 | $3,760,484 | 0.76% |
| Acuitas Investments, LLC | 329,164 | $934,826 | 0.55% |
| Aldebaran Capital, LLC | 143,739 | $408,219 | 0.42% |
| Bulldog Investors, LLP | 200,000 | $568,000 | 0.20% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 416,200 | $1,182,008 | 0.19% |
| Alta Fundamental Advisers LLC | 117,346 | $333,263 | 0.16% |